AGEE NANCY H 4

What Happened Nancy H. Agee, a director of Precigen, received stock awards on March 10, 2026. The filing shows (1) 16,096 common shares issued in lieu of an annual retainer (reported at $3.51/share, total $56,497) and (2) two restricted stock unit (RSU) awards totaling 76,685 RSUs (35,612 RSUs and 41,073 RSUs) reported at $0 as derivatives. Transaction code A indicates these were grants/awards (compensation), not open‑market purchases or sales.

Key Details

• Transaction date: March 10, 2026. Form 4 filed March 12, 2026 (timely).
• Awarded: 16,096 shares @ $3.51 = $56,497 (issued in lieu of a $56,500 annual retainer) [Footnote F1].
• RSUs: 35,612 RSUs and 41,073 RSUs (76,685 total); each RSU equals a contingent right to one share [F2]; reported price $0 (derivative).
• Vesting: RSUs vest in full on March 10, 2027 [F3].
• Shares owned after the reported transaction: not specified in the filing.

Context These entries are compensation awards (code A). The common shares were issued as retainer payment and are immediately issued; the RSUs are contingent and do not represent immediately tradable stock until they vest (one year from grant). Awards like this are routine executive/director compensation and are not the same signal as an open‑market purchase.